TWO SIGMA ADVISERS, LP - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 102 filers reported holding ANTARES PHARMA INC in Q1 2018. The put-call ratio across all filers is 1.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q1 2022$2,356,000
-1.0%
574,732
-13.8%
0.01%0.0%
Q4 2021$2,380,000
-44.1%
666,532
-43.0%
0.01%
-45.5%
Q3 2021$4,260,000
-25.5%
1,170,332
-10.7%
0.01%
-26.7%
Q2 2021$5,717,000
+17.4%
1,311,232
+10.7%
0.02%
+15.4%
Q1 2021$4,868,000
-0.4%
1,184,432
-3.3%
0.01%0.0%
Q4 2020$4,886,000
+36.0%
1,224,632
-7.9%
0.01%
+30.0%
Q3 2020$3,592,000
-21.0%
1,330,232
-19.6%
0.01%
-23.1%
Q2 2020$4,547,000
+23.0%
1,653,532
+5.5%
0.01%
-7.1%
Q1 2020$3,698,000
-43.3%
1,566,832
+12.9%
0.01%
-6.7%
Q4 2019$6,523,000
+337.8%
1,387,932
+211.7%
0.02%
+275.0%
Q3 2019$1,490,000
+2.5%
445,332
+0.9%
0.00%0.0%
Q2 2019$1,453,000
+22.2%
441,532
+12.5%
0.00%
+33.3%
Q1 2019$1,189,000
+35.1%
392,532
+21.3%
0.00%
+50.0%
Q4 2018$880,000
+126.8%
323,632
+180.1%
0.00%
+100.0%
Q3 2018$388,000
+725.5%
115,532
+441.6%
0.00%
Q1 2018$47,000
-60.8%
21,332
-64.6%
0.00%
Q4 2017$120,000
-34.1%
60,319
+7.4%
0.00%
-100.0%
Q3 2017$182,000
+180.0%
56,185
+179.5%
0.00%
Q2 2017$65,000
+209.5%
20,100
-1.0%
0.00%
Q2 2016$21,000
+16.7%
20,300
+0.5%
0.00%
Q1 2016$18,00020,2000.00%
Other shareholders
ANTARES PHARMA INC shareholders Q1 2018
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 3,130,192$12,834,0005.32%
Velan Capital Investment Management LP 1,346,971$5,523,0005.12%
FIRST WILSHIRE SECURITIES MANAGEMENT INC 2,799,953$11,480,0004.03%
Sargent Investment Group, LLC 3,663,275$15,019,0003.78%
PERKINS CAPITAL MANAGEMENT INC 481,483$1,974,0001.62%
Rubric Capital Management LP 10,900,000$44,690,0001.62%
ORACLE INVESTMENT MANAGEMENT INC 1,720,000$7,052,0001.39%
Long Focus Capital Management, LLC 540,000$2,214,0000.28%
OBERWEIS ASSET MANAGEMENT INC/ 344,200$1,411,0000.28%
FIRETHORN WEALTH PARTNERS, LLC 84,069$345,0000.26%
View complete list of ANTARES PHARMA INC shareholders